MDT MD

MDT Medtronic plc.

Healthcare · Medical Devices

7 · Fair Momentum 6.0 · Neutral Safe Aristocrat

92.39

-1.89%

About the company

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

3.12%
70.94%
2.88
118.2B
22.76
4.06
89.72

52-week range

92.4
low 73.3 high 106
Yield Growth Momentum Safety Value Health

Dividend deep dive

Medtronic plc. (MDT) operates in the Medical Devices industry within the Healthcare sector. The company currently offers a dividend yield of 3.12%. This yield is above its 5-year average of 2.96% and falls within its 5-year yield band of 2.09% to 3.35%. Medtronic is recognized as a Dividend Champion with 28 consecutive years of dividend increases. Valuation analysis indicates its price is considered fair by Yield Theory, although one fair value model suggests it is currently expensive, being 33.4% above a fair value of USD 61.55.

Dividend history

Medtronic plc. has demonstrated consistent dividend growth, maintaining a streak of 28 consecutive years of increases, earning it a Dividend Champion status. Over the past three years, the dividend has grown at a CAGR of 1.45%, while the five-year CAGR stands at 4.13%. Annual dividends per share have progressed from USD 1.22 in 2014 to USD 1.84 in 2017, USD 2.16 in 2019, USD 2.52 in 2021, and USD 2.80 in 2024. The projected dividend for 2025 is USD 2.84.

Dividend safety

The dividend safety for Medtronic plc. shows a payout ratio of 70.94% based on earnings, indicating a significant portion of earnings is distributed as dividends. The company's financial health includes a debt-to-equity ratio of 55.365%.

Quantic · Free

Read the rest of the safety verdict

Plus the key risks and what to watch next — free, no card.

AI-generated from Quantic's dividend data · Updated 9 Sep 2026 · Information, not financial advice.

Price history

133 102 70.6 2021 2022 2023 2024 2025 2026 2020-10 · 101 2020-11 · 114 2020-12 · 117 2021-01 · 111 2021-02 · 117 2021-03 · 118 2021-04 · 131 2021-05 · 127 2021-06 · 124 2021-07 · 131 2021-08 · 133 2021-09 · 125 2021-10 · 120 2021-11 · 107 2021-12 · 103 2022-01 · 103 2022-02 · 105 2022-03 · 111 2022-04 · 104 2022-05 · 100 2022-06 · 89.8 2022-07 · 92.5 2022-08 · 87.9 2022-09 · 80.8 2022-10 · 87.3 2022-11 · 79.0 2022-12 · 77.7 2023-01 · 83.7 2023-02 · 82.8 2023-03 · 80.6 2023-04 · 91.0 2023-05 · 82.8 2023-06 · 88.1 2023-07 · 87.8 2023-08 · 81.5 2023-09 · 78.4 2023-10 · 70.6 2023-11 · 79.3 2023-12 · 82.4 2024-01 · 87.5 2024-02 · 83.4 2024-03 · 87.2 2024-04 · 80.2 2024-05 · 81.4 2024-06 · 78.7 2024-07 · 80.3 2024-08 · 88.6 2024-09 · 90.0 2024-10 · 89.3 2024-11 · 86.5 2024-12 · 79.9 2025-01 · 90.8 2025-02 · 92.0 2025-03 · 89.9 2025-04 · 84.8 2025-05 · 83.0 2025-06 · 87.2 2025-07 · 90.2 2025-08 · 92.8 2025-09 · 95.2 2025-10 · 90.7 2025-11 · 105 2025-12 · 96.1 2026-01 · 103 2026-02 · 97.7 2026-03 · 86.7 2026-04 · 81.0 2026-05 · 73.8 2026-06 · 78.2 2026-07 · 85.4 2026-08 · 90.7 2026-09 · 92.4
Price

Dividend profile

Frequency
Quarterly
Growth (TTM)
+1.4%
CAGR 3y
+1.4%
+4.1%
28 years

(5-year)

Now 3.1%
2.1% avg 3.0% 3.4%

Payment calendar

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Dividend history

CAGR 3y +1.4% CAGR 5y +4.1% 28y streak
14 15 16 17 18 19 20 21 22 23 24 25

Per-share dividend by year

Quantic · Free

Unlock valuation & strategy

Two DDM fair values, margin of safety, sector value rank, Dividend Yield Theory, doubling time and max drawdown.

Debt & leverage

55.4%
2.07
1.29
Debt vs cash
Debt Cash
Total debt
28.2B USD
Total cash
8.8B USD
10.4B USD

Latest reported balance-sheet figures.

Held by 1 investor

Appears in these lists

MDT qualifies for these curated dividend rankings.

Information, not financial advice.

Quantic · Free

Track MDT and your whole portfolio

Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.

€0

Need more? Pro adds portfolios, options income tracking & more AI. See Pro →